Lv1
60 积分 2024-02-19 加入
Lessons from TROPiCS-04: 'safety-first' for success in late-stage clinical trials
1天前
已完结
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
1天前
已完结
HER2-targeted therapies beyond breast cancer - an update
1天前
已完结
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
20天前
已完结
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
1个月前
已完结
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
1个月前
已完结
非小细胞肺癌新辅助治疗疗效病理评估专家共识
1个月前
已完结
中国抗癌协会乳腺癌诊治指南与规范(2024年版)
2个月前
已完结
中国晚期三阴性乳腺癌临床诊疗指南（2024版）
2个月前
已完结
中国晚期乳腺癌规范诊疗指南（2024版）
2个月前
已完结
皖公网安备34019202002308
